ASC42

· Gannex Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ASC42, covering 2024-04-04 to 2024-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis [Phase 2]